Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2007
Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding abilityRoy H Larsen, Jorgen Borrebaek, Jostein Dahle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2009
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate (227)Th-rituximabJostein Dahle, Thora J Jonasdottir, Helen Heyerdahl, et al.
Nuclear Medicine and Biology|March 21, 2006
Initial evaluation of (227)Th-p-benzyl-DOTA-rituximab for low-dose rate alpha-particle radioimmunotherapyJostein Dahle, Jørgen Borrebaek, Katrine B Melhus, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
A Phase II Study of 177Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma PatientsRoy H Larsen, Arne Kolstad, Alexander Fosså, et al.
Plos One|October 25, 2016
Evaluation of CD146 as Target for Radioimmunotherapy against OsteosarcomaSara Westrøm, Tina B Bønsdorff, Nasir Abbas, et al.
European Journal of Haematology|July 12, 2018
Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphomaAda H V Repetto-Llamazares, Marion M Malenge, Adam O'Shea, et al.
Plos One|July 29, 2014
177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude miceAda H V Repetto-Llamazares, Roy H Larsen, Anna Maria Giusti, et al.
Anticancer Research|December 26, 2012
Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphomaJostein Dahle, Ada H V Repetto-Llamazares, Camilla S Mollatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastasesSten Nilsson, Roy H Larsen, Sophie D Fosså, et al.
In Vivo (Athens, Greece)|May 27, 2006
Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematologyRoy H Larsen, Henrik Saxtorph, Mikala Skydsgaard, et al.
Pageof 4